フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
NeonMind Advances Strategy for Specialty Clinic Launch Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded...
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo...
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Company Broadens Scientific...
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceVancouver, B.C. - September 8, 2021: NeonMind Biosciences Inc...
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board Vancouver, B.C. – July 28, 2021...
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US Vancouver, B.C., Canada -- June 29, 2021...
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products Vancouver, B.C. - June 9, 2021 -- InvestorsHub NewsWire -- NeonMind...
NeonMind to Commence Trading on the OTCQB Venture MarketVancouver, B.C. - May 28, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE:...
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions Vancouver, B.C. – April 6, 2021 -- InvestorsHub NewsWire...
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity Vancouver, B.C. - March 9, 2021: NeonMind...
NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial Vancouver, B.C. –...
NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer Vancouver, B.C. -- January 27, 2021 -- InvestorsHub...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約